Search Results 7811-7820 of 26217 for oral
... oral contraceptives, double-barrier methods such as a condom and a diaphragm, intrauterine device) during the study and for 4 months following the last dose ...
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study. Invest New Drugs ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep Medicine in Minnesota · Sleep Medicine · Sleep Surgery Clinic ...
Oral and Maxillofacial Surgery Residency, M.D.-O.M.S. (Minnesota) · Orthopedic Sports Medicine Fellowship (Arizona) · Orthopedic Sports Medicine Fellowship ...
Patients must not require concomitant treatment with oral anticoagulants (e.g., warfarin, direct thrombin, and factor Xa inhibitors) or platelet inhibitors ( ...
At the discretion of the Investigator, 0.5 to 1 mg may be given orally prior to scan with a single repeat dose given if the first dose is ineffective.
... oral contraceptives are also used; all sexually active subjects of reproduction potential must agree to use both a barrier method and a second method of ...
Your surgeon might prescribe an injected or oral blood thinner after surgery. Depending on how soon you walk, how active you are and your overall risk of ...
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection.
For more information, visit http://www.ypo.org. Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients · Have Questions About ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.